Index S&P 500 P/E 204.44 EPS (ttm) 0.38 Insider Own 0.15% Shs Outstand 1.27B Perf Week 0.80%
Market Cap 99.32B Forward P/E 10.90 EPS next Y 7.18 Insider Trans -0.39% Shs Float 1.27B Perf Month -0.95%
Enterprise Value 169.97B PEG 0.74 EPS next Q 0.98 Inst Own 89.04% Short Float 1.55% Perf Quarter 5.77%
Income 469.00M P/S 0.25 EPS this Y 22.66% Inst Trans 1.09% Short Ratio 2.61 Perf Half Y 21.76%
Sales 393.94B P/B 1.36 EPS next Y 7.94% ROA 0.18% Short Interest 19.63M Perf YTD 74.29%
Book/sh 57.42 P/C 8.80 EPS next 5Y 14.64% ROE 0.63% 52W High 85.15 -8.12% Perf Year 37.60%
Cash/sh 8.89 P/FCF 15.78 EPS past 3/5Y -14.99% -6.37% ROIC 0.32% 52W Low 43.56 79.61% Perf 3Y -23.73%
Dividend Est. 2.66 (3.40%) EV/EBITDA 9.90 Sales past 3/5Y 8.48% 7.75% Gross Margin 13.85% Volatility 3.09% 2.54% Perf 5Y 12.37%
Dividend TTM 2.66 (3.40%) EV/Sales 0.43 EPS Y/Y TTM -90.11% Oper. Margin 3.19% ATR (14) 2.11 Perf 10Y -18.03%
Dividend Ex-Date Oct 23, 2025 Quick Ratio 0.63 Sales Y/Y TTM 6.71% Profit Margin 0.12% RSI (14) 51.05 Recom 1.55
Dividend Gr. 3/5Y 9.07% 5.87% Current Ratio 0.83 EPS Q/Q -4633.14% SMA20 0.33% Beta 0.49 Target Price 93.92
Payout 72.76% Debt/Eq 1.12 Sales Q/Q 7.83% SMA50 -0.61% Rel Volume 1.68 Prev Close 76.53
Employees 300000 LT Debt/Eq 1.02 Earnings Oct 29 BMO SMA200 12.06% Avg Volume 7.52M Price 78.24
IPO Oct 01, 1952 Option/Short Yes / Yes EPS/Sales Surpr. 17.21% 4.11% Trades
Volume 12,602,166 Change 2.23%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-14-25 Initiated Goldman
Buy
$91
Aug-18-25 Upgrade UBS
Neutral → Buy
$79
Aug-14-25 Upgrade Robert W. Baird
Neutral → Outperform
$82
Feb-13-25 Upgrade Leerink Partners
Market Perform → Outperform
$55 → $75
Feb-12-25 Upgrade Cantor Fitzgerald
Neutral → Overweight
Jan-30-25 Upgrade Edward Jones
Hold → Buy
Dec-03-24 Upgrade Deutsche Bank
Hold → Buy
$66
Nov-18-24 Upgrade Wells Fargo
Equal Weight → Overweight
$60 → $66
Oct-10-24 Upgrade Barclays
Equal Weight → Overweight
$63 → $82
Oct-04-24 Upgrade TD Cowen
Hold → Buy
$59 → $85
May-30-24 Initiated Robert W. Baird
Neutral
$61
May-07-24 Downgrade TD Cowen
Buy → Hold
$99 → $59
May-02-24 Downgrade UBS
Buy → Neutral
$85 → $60
May-01-24 Downgrade Leerink Partners
Outperform → Market Perform
$87 → $60
May-01-24 Downgrade Cantor Fitzgerald
Overweight → Neutral
Mar-06-24 Initiated Barclays
Equal Weight
$78
Feb-26-24 Initiated Leerink Partners
Outperform
$88
Dec-22-23 Initiated HSBC Securities
Buy
$94
Sep-19-23 Upgrade Evercore ISI
In-line → Outperform
$81 → $83
Sep-12-23 Upgrade Wolfe Research
Peer Perform → Outperform
$80
Show Previous Ratings
Dec-09-25 11:02PM
09:49PM
07:37PM
06:27PM
(The Wall Street Journal)
05:06PM
(The Wall Street Journal)
04:30PM
Loading…
04:30PM
04:26PM
03:25PM
03:05PM
(The Wall Street Journal)
02:54PM
01:33PM
11:21AM
11:19AM
10:23AM
10:10AM
(The Wall Street Journal)
09:28AM
Loading…
09:28AM
07:39AM
(The Wall Street Journal)
07:35AM
06:30AM
Dec-08-25 09:40AM
Dec-05-25 09:00AM
Dec-04-25 08:00AM
07:57AM
05:51AM
Dec-03-25 10:36PM
03:11PM
09:00AM
Dec-01-25 12:17PM
10:00AM
Nov-28-25 05:30PM
11:30AM
Loading…
11:30AM
07:08AM
05:47AM
Nov-26-25 02:05PM
10:58AM
Nov-25-25 10:03AM
08:18AM
Nov-24-25 05:13AM
Nov-23-25 05:30AM
(The Wall Street Journal)
Nov-21-25 08:00AM
(Investor's Business Daily)
Nov-20-25 04:05PM
09:41AM
09:40AM
09:00AM
Nov-19-25 07:37PM
09:00AM
05:19AM
Nov-18-25 11:00AM
Nov-17-25 11:23AM
07:41AM
Nov-14-25 11:50PM
05:08PM
04:13PM
Nov-13-25 07:26AM
Nov-12-25 03:17PM
11:01AM
09:37AM
09:31AM
02:28AM
Nov-11-25 07:53AM
04:20AM
Nov-10-25 12:47PM
09:07AM
(Investor's Business Daily)
09:00AM
07:03AM
(The Wall Street Journal)
Nov-09-25 11:05AM
Nov-08-25 05:45AM
Nov-07-25 11:06PM
Nov-05-25 04:23PM
12:23PM
09:00AM
12:37AM
Nov-04-25 11:22AM
09:45AM
(Associated Press Finance)
06:57AM
05:17AM
Oct-31-25 03:10PM
Oct-30-25 05:51PM
04:45PM
04:06PM
03:51PM
03:35PM
01:25PM
10:52AM
07:11AM
01:33AM
Oct-29-25 10:03PM
04:15PM
04:14PM
12:00PM
(The Wall Street Journal)
11:18AM
11:04AM
10:50AM
10:04AM
09:31AM
(The Wall Street Journal)
09:31AM
09:30AM
09:00AM
08:12AM
(Associated Press Finance)
08:03AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Finucane Anne A. Director Aug 20 '25 Sale 71.02 7,500 532,650 22,156 Aug 29 04:29 PM Finucane Anne A. Director Aug 20 '25 Proposed Sale 70.97 7,500 532,275 Aug 19 06:57 PM SANSONE GUY P Director Jun 05 '25 Buy 63.70 1,570 100,009 12,007 Jun 09 08:22 AM ROBBINS LARRY Director May 02 '25 Sale 67.86 2,276,068 154,444,758 9,670,731 May 06 04:15 PM ROBBINS LARRY Director May 05 '25 Sale 67.41 1,323,932 89,249,945 8,346,799 May 06 04:15 PM ROBBINS LARRY Director May 06 '25 Sale 66.67 150,000 10,000,710 8,196,799 May 06 04:15 PM Shah Prem S EVP and Group President Mar 17 '25 Option Exercise 62.21 846 52,630 43,190 Mar 18 04:51 PM Clark James David SVP, Cont & Chief Acct Officer Mar 05 '25 Option Exercise 62.21 7,513 467,384 15,907 Mar 07 04:56 PM Clark James David SVP, Cont & Chief Acct Officer Mar 05 '25 Sale 66.35 7,513 498,488 8,394 Mar 07 04:56 PM Clark James David Officer Mar 05 '25 Proposed Sale 66.35 7,513 498,489 Mar 05 05:25 PM Mahoney Michael F Director Feb 18 '25 Buy 66.70 30,000 2,001,000 39,356 Feb 19 12:35 PM
